X0306 4 2018-08-02 0000816956 CONMED CORP CNMD 0001238334 JONAS DANIEL C/O CONMED CORP 525 FRENCH ROAD UTICA NY 13502-5994 1 EVP Legal Affairs,Gen. Counsel Common Stock 2018-08-02 4 M 0 2000 32.93 A 20347 D Common Stock 2018-08-02 4 F 0 1221 80.40 D 19126 D Common Stock 2018-08-02 4 M 0 1560 44.90 A 20686 D Common Stock 2018-08-02 4 F 0 1106 80.40 D 19580 D Common Stock 2018-08-02 4 M 0 12000 51.30 A 31580 D Common Stock 2018-08-02 4 F 0 9133 80.40 D 22447 D Common Stock 2018-08-02 4 S 0 4000 79.73 D 18447 D Sars (Stock Appreciation Rights) 32.93 2018-08-02 4 M 0 2000 0 D 2023-06-01 Common Stock 2000 0 D Sars (Stock Appreciation Rights) 44.90 2018-08-02 4 M 0 1560 0 D 2024-06-01 Common Stock 1560 1560 D Sars (Stock Appreciation Rights) 51.30 2018-08-02 4 M 0 12000 0 D 2025-02-27 Common Stock 12000 12800 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.54 to $80.13. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder. The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (20%) over a five year period. Daniel S. Jonas 2018-08-06